October 24, 2013—The federal government and drug manufacturers have agreed to fast-track the industry’s lawsuit challenging the legality of the 340B orphan drug exclusion regulation.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)